Cathay Biotech Inc. (SHA:688065)
China flag China · Delayed Price · Currency is CNY
47.45
-1.18 (-2.43%)
Oct 17, 2025, 3:00 PM CST

Cathay Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
34,19522,55532,01235,74976,78635,439
Upgrade
Market Cap Growth
73.42%-29.54%-10.45%-53.44%116.67%-
Upgrade
Enterprise Value
28,54922,81831,82333,87871,14229,114
Upgrade
Last Close Price
47.4538.4854.2660.32128.9959.08
Upgrade
PE Ratio
53.1246.1387.3464.61129.1177.43
Upgrade
Forward PE
52.1429.6146.7489.6189.6156.23
Upgrade
PS Ratio
10.747.6315.1414.6532.4923.67
Upgrade
PB Ratio
1.621.492.172.385.233.09
Upgrade
P/TBV Ratio
2.042.083.063.527.773.49
Upgrade
P/OCF Ratio
47.1827.4856.2244.48132.6968.82
Upgrade
EV/Sales Ratio
8.977.7115.0513.8830.1019.45
Upgrade
EV/EBITDA Ratio
40.5033.5670.5250.43106.5351.48
Upgrade
EV/EBIT Ratio
72.5062.70192.2383.32142.5065.10
Upgrade
Debt / Equity Ratio
0.030.130.120.080.05-
Upgrade
Debt / EBITDA Ratio
0.782.793.941.681.11-
Upgrade
Asset Turnover
0.150.160.120.140.170.17
Upgrade
Inventory Turnover
1.821.601.011.171.561.01
Upgrade
Quick Ratio
5.541.991.704.758.1416.89
Upgrade
Current Ratio
6.402.532.225.959.3619.42
Upgrade
Return on Equity (ROE)
2.86%3.18%2.74%4.12%4.84%5.67%
Upgrade
Return on Assets (ROA)
1.19%1.20%0.56%1.49%2.20%3.08%
Upgrade
Return on Capital (ROIC)
1.33%1.36%0.63%1.61%2.32%3.40%
Upgrade
Return on Capital Employed (ROCE)
1.80%2.30%1.10%2.50%3.30%3.80%
Upgrade
Earnings Yield
1.61%2.17%1.15%1.55%0.78%1.29%
Upgrade
FCF Yield
0.26%-0.10%-3.13%-9.50%-1.15%-0.70%
Upgrade
Dividend Yield
0.84%1.04%0.35%0.30%0.25%0.97%
Upgrade
Payout Ratio
25.48%28.80%37.58%37.39%57.11%0.85%
Upgrade
Buyback Yield / Dilution
-5.93%-0.05%0.10%0.11%-7.38%-6.91%
Upgrade
Total Shareholder Return
-5.09%0.99%0.45%0.41%-7.13%-5.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.